Literature DB >> 25045592

Morphine has latent deleterious effects on the ventilatory responses to a hypoxic-hypercapnic challenge.

Walter J May1, Fraser Henderson1, Ryan B Gruber2, Joseph F Discala2, Alex P Young1, James N Bates3, Lisa A Palmer1, Stephen J Lewis1.   

Abstract

This study explored the concept that morphine has latent deleterious actions on the ventilatory control systems that respond to a hypoxic-hypercapnic challenge. In this study, we examined the ventilatory responses elicited by hypoxic-hypercapnic challenge in conscious rats at a time when the effects of morphine (10 mg/kg) on arterial blood-gas chemistry and minute ventilation had subsided. Morphine induced pronounced changes in arterial blood-gas chemistry (e.g., an increase in pCO2, decreases in pO2 and sO2) and decreases in minute ventilation. Despite the complete resolution of the morphine-induced changes in arterial blood-gas chemistry and minute ventilation and almost complete resolution of the effects on peak inspiratory flow and peak expiratory flow, subsequent exposure to hypoxic-hypercapnic challenge elicited markedly blunted increases in minute ventilation and in peak inspiratory and expiratory flows. These findings demonstrate that (1) the changes in arterial blood-gas chemistry elicited by morphine parallel changes in minute ventilation rather than PIF and PEF, and (2) morphine has latent untoward effects on the ventilatory responses to hypoxic-hypercapnic challenge. These novel findings raise the possibility that patients deemed to have recovered from the acute ventilatory depressant effects of morphine may still be susceptible to the latent effects of this opioid analgesic. The mechanisms underlying these latent effects remain to be elucidated.

Entities:  

Keywords:  Arterial Blood Gases; Conscious Rats; Hypoxia-Hypercapnia; Minute Ventilation; Morphine

Year:  2013        PMID: 25045592      PMCID: PMC4103749          DOI: 10.4236/ojmip.2013.33019

Source DB:  PubMed          Journal:  Open J Mol Integr Physiol        ISSN: 2162-2167


  64 in total

1.  The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver.

Authors:  Yoshitaka Hasegawa; Shuichi Kishimoto; Naoki Shibatani; Hiromichi Nomura; Yuko Ishii; Mika Onishi; Nobuo Inotsume; Yoshikazu Takeuchi; Shoji Fukushima
Journal:  J Pharm Pharmacol       Date:  2010-03       Impact factor: 3.765

Review 2.  Opioids, sleep architecture and sleep-disordered breathing.

Authors:  David Wang; Harry Teichtahl
Journal:  Sleep Med Rev       Date:  2006-12-01       Impact factor: 11.609

3.  Alterations in diaphragm EMG activity during opiate-induced respiratory depression.

Authors:  C Campbell; M B Weinger; M Quinn
Journal:  Respir Physiol       Date:  1995-05

4.  A simple approach to validation of directed-flow nose-only inhalation chambers.

Authors:  Jürgen Pauluhn; Achim Thiel
Journal:  J Appl Toxicol       Date:  2007 Mar-Apr       Impact factor: 3.446

Review 5.  Circadian patterns of breathing.

Authors:  Jacopo P Mortola; Erin L Seifert
Journal:  Respir Physiol Neurobiol       Date:  2002-07       Impact factor: 1.931

6.  Morphine-6-glucuronide: effects on ventilation in normal volunteers.

Authors:  S J Peat; M H Hanna; M Woodham; A A Knibb; J Ponte
Journal:  Pain       Date:  1991-04       Impact factor: 6.961

7.  Activation of the retrotrapezoid nucleus by posterior hypothalamic stimulation.

Authors:  Michal G Fortuna; Ruth L Stornetta; Gavin H West; Patrice G Guyenet
Journal:  J Physiol       Date:  2009-09-14       Impact factor: 5.182

8.  Effect of elevated PICO2 on metabolic rate in humans and ponies.

Authors:  R P Kaminski; H V Forster; J P Klein; L G Pan; G E Bisgard; L H Hamilton
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-06

9.  [Effects of morphine on the control of the cardiovascular system by the carotid-sinus-reflex and by the carotid chemoreflex].

Authors:  M Zimpfer; A Beck; N Mayer; G Raberger; K Steinbereithner
Journal:  Anaesthesist       Date:  1983-02       Impact factor: 1.041

Review 10.  Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data.

Authors:  J N Cashman; S J Dolin
Journal:  Br J Anaesth       Date:  2004-05-28       Impact factor: 9.166

View more
  11 in total

1.  S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Ryan B Gruber; Benjamin Gaston; Tristan H J Lewis; Alan Grossfield; James M Seckler; Yee-Hsee Hsieh; James N Bates; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

2.  D-cysteine ethyl ester and D-cystine dimethyl ester reverse the deleterious effects of morphine on arterial blood-gas chemistry and Alveolar-arterial gradient in anesthetized rats.

Authors:  Paulina M Getsy; Alex P Young; Alan Grossfield; James M Seckler; Christopher G Wilson; Benjamin Gaston; James N Bates; Stephen J Lewis
Journal:  Respir Physiol Neurobiol       Date:  2022-04-18       Impact factor: 2.821

3.  Bilateral carotid sinus nerve transection exacerbates morphine-induced respiratory depression.

Authors:  Santhosh M Baby; Ryan B Gruber; Alex P Young; Peter M MacFarlane; Luc J Teppema; Stephen J Lewis
Journal:  Eur J Pharmacol       Date:  2018-07-19       Impact factor: 4.432

4.  D-Cystine di(m)ethyl ester reverses the deleterious effects of morphine on ventilation and arterial blood gas chemistry while promoting antinociception.

Authors:  Benjamin Gaston; Santhosh M Baby; Walter J May; Alex P Young; Alan Grossfield; James N Bates; James M Seckler; Christopher G Wilson; Stephen J Lewis
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

5.  Glutathione ethyl ester reverses the deleterious effects of fentanyl on ventilation and arterial blood-gas chemistry while prolonging fentanyl-induced analgesia.

Authors:  Michael W Jenkins; Faiza Khalid; Santhosh M Baby; Walter J May; Alex P Young; James N Bates; Feixiong Cheng; James M Seckler; Stephen J Lewis
Journal:  Sci Rep       Date:  2021-03-26       Impact factor: 4.379

6.  D-Cysteine Ethyl Ester Reverses the Deleterious Effects of Morphine on Breathing and Arterial Blood-Gas Chemistry in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Walter J May; Alex P Young; Benjamin Gaston; Matthew R Hodges; Hubert V Forster; James N Bates; Christopher G Wilson; Tristan H J Lewis; Yee-Hee Hsieh; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

7.  S-nitroso-L-cysteine stereoselectively blunts the adverse effects of morphine on breathing and arterial blood gas chemistry while promoting analgesia.

Authors:  Paulina M Getsy; Alex P Young; James N Bates; Santhosh M Baby; James M Seckler; Alan Grossfield; Yee-Hsee Hsieh; Tristan H J Lewis; Michael W Jenkins; Benjamin Gaston; Stephen J Lewis
Journal:  Biomed Pharmacother       Date:  2022-07-26       Impact factor: 7.419

8.  Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl.

Authors:  Santhosh Baby; Ryan Gruber; Joseph Discala; Veljko Puskovic; Nijo Jose; Feixiong Cheng; Michael Jenkins; James Seckler; Stephen Lewis
Journal:  Front Pharmacol       Date:  2021-06-23       Impact factor: 5.810

9.  The use of hypercapnic conditions to assess opioid-induced respiratory depression in rats.

Authors:  Morgan L Crowley; Luis F Restrepo; Lea R Gamez-Jimenez; Avi Patel; Tobias Braun; Victoria L C Pallares; Nicholas P Ho; Morgan E Reeves; Christopher R McCurdy; Lance R McMahon; Takato Hiranita
Journal:  J Pharmacol Toxicol Methods       Date:  2021-07-07       Impact factor: 2.285

10.  Genetic variation regulates opioid-induced respiratory depression in mice.

Authors:  Jason A Bubier; Hao He; Vivek M Philip; Tyler Roy; Christian Monroy Hernandez; Rebecca Bernat; Kevin D Donohue; Bruce F O'Hara; Elissa J Chesler
Journal:  Sci Rep       Date:  2020-09-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.